Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Group A: Adults over 18 years old who have a lung nodule or lung mass and either: are being monitored with routine CT scans without needing further tests yet, or are not in a standard screening programme but have been advised to have a follow-up CT scan rather than immediate further tests — as recommended by a specialist team meeting.
- Group B: Adults over 18 years old for whom a specialist team meeting has recommended a biopsy or surgical removal of a lung nodule or mass for diagnosis or treatment.
- Group C – Smoking history option 1: People aged 40–75 who have smoked every day for at least 20 years and started smoking before age 15.
- Group C – Smoking history option 2: People aged 50–75 who have been regularly exposed to other people's smoke for at least 20 years in an enclosed space such as at home or at work.
- Group C – Smoking history option 3: People aged 50–75 who have smoked at least 10 cigarettes per day for 30 years, or 15 per day for 25 years, or the equivalent of 20 pack-years, with no period of stopping.
- Group C – Smoking history option 4: People aged 50–75 who have smoked every day for at least 10 years and also have at least one additional lung cancer risk factor, which may include: regular exposure to second-hand smoke for more than 10 years in an enclosed space; reported workplace or environmental exposure to substances such as radon, coal smoke, soot, diesel fumes, nickel, beryllium, arsenic, cadmium, or asbestos; a parent, sibling, or child who has had lung cancer; a personal history of a tobacco-related illness such as heart or blood vessel disease, COPD, emphysema, or a cancer not already being monitored by chest scans; or weekly cannabis (joint) use for 10 years.
- All groups: Participants must have signed a consent form agreeing to take part, must be covered by a social security scheme, and may be male or female.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- Groups A and B: People for whom a lung biopsy or chest surgery would be medically unsafe or not recommended.
- Group C: People who already meet the national criteria set by INCa (the French National Cancer Institute) for standard lung cancer screening (confirm with trial site).
- People who have had a cancer diagnosis within the last 5 years — though certain exceptions may apply, including some early-stage or treated cancers such as cervical carcinoma in situ, basal cell skin cancer, a specific type of treated bladder cancer, or prostate cancer with undetectable PSA levels (confirm with trial site).
- People who are currently experiencing symptoms that may suggest lung cancer, such as unintentional weight loss of more than 10% of their usual body weight within one year, or coughing up blood.
- People with a known history of a lung nodule that has already required specialist monitoring.
- People with a history of pulmonary fibrosis (scarring of the lungs) or pulmonary hypertension (high blood pressure in the lungs).
- People with an active lung infection.
- People with severe heart or breathing problems that cause breathlessness at rest.
- People with a performance status (a medical measure of general health and ability to carry out daily activities) rated at 2, 3, or 4 on the World Health Organization scale, indicating significant limitations (confirm with trial site).
- All groups: People who are currently imprisoned or have restricted personal freedom.
- All groups: People who are under legal guardianship or a court-appointed protection order (confirm with trial site).
- All groups: People who are pregnant or breastfeeding.
- All groups: People who would be unable to complete the 30-month follow-up period required by the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: David Boulate, Professor of Medicine, Assistance Publique Hopitaux De Marseille
Phone: +33 491966018
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Sensitivity and specificity of the radiomics algorithm for characterizing benign vs. malignant lung lesions.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.